API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/cstone-pharmaceuticals-and-blueprint-medicines-initiate-phase-1b2-clinical-trial-of-fisogatinib-in-combination-with-cs1001-for-patients-with-hepatocellular-carcinoma-300981035.html
https://www.prnewswire.com/news-releases/cstone-receives-cta-approval-in-china-to-start-phase-i-trial-for-fgfr4-inhibitor-blu-554-cs3008-300785598.html
http://ir.blueprintmedicines.com/phoenix.zhtml?c=253931&p=irol-newsArticle&ID=2354759
http://ir.blueprintmedicines.com/phoenix.zhtml?c=253931&p=irol-newsArticle&ID=2355440